| Epidemiology and survival outcomes of ocular and mucosal melanomas: A population‐based analysis KD Bishop, AJ Olszewski International journal of cancer 134 (12), 2961-2971, 2014 | 206 | 2014 |
| Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells JE Harris, KD Bishop, NE Phillips, JP Mordes, DL Greiner, AA Rossini, ... The Journal of Immunology 173 (12), 7331-7338, 2004 | 161 | 2004 |
| Compliance and falsification of duty hours: reports from residents and program directors BC Drolet, M Schwede, KD Bishop, SA Fischer Journal of graduate medical education 5 (3), 368-373, 2013 | 46 | 2013 |
| A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3 JL Hillebrands, B Whalen, JTJ Visser, J Koning, KD Bishop, J Leif, ... The Journal of Immunology 177 (11), 7820-7832, 2006 | 46 | 2006 |
| Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4+ T lymphocytes via an interleukin-2-dependent mechanism KD Bishop, JE Harris, JP Mordes, DL Greiner, AA Rossini, MP Czech, ... Cellular immunology 256 (1), 86-91, 2009 | 37 | 2009 |
| Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies JJ Castillo, JL Reagan, KD Bishop, E Apor British journal of haematology 165 (3), 300-315, 2014 | 28 | 2014 |
| Risk factors associated with Clostridium difficile infection in adult oncology patients with a history of recent hospitalization for febrile neutropenia KD Bishop, JJ Castillo Leukemia & lymphoma 53 (8), 1617-1619, 2012 | 26 | 2012 |
| FOLFOX+ nab-paclitaxel (FOLFOX-A) for advanced pancreatic Cancer: a Brown University oncology research group phase I study H Safran, KP Charpentier, K Perez, K Mantripragada, T Miner, T DiPetrillo, ... American journal of clinical oncology 39 (6), 619-622, 2016 | 16 | 2016 |
| Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies JJ Castillo, M Iyengar, B Kuritzky, KD Bishop OncoTargets and therapy, 333-342, 2014 | 12 | 2014 |
| Painless neutropenic enterocolitis in a patient undergoing chemotherapy EJ Chow, KD Bishop Current Oncology 23 (5), 514-516, 2016 | 6 | 2016 |
| Nab-paclitaxel (nab-P) combined with FOLFOX for advanced pancreatic cancer: A phase I study. H Safran, K Perez, K Charpentier, TC Austin, KC Mantripragada, ... Journal of Clinical Oncology 32 (15_suppl), 4123-4123, 2014 | 6 | 2014 |
| Lenalidomide for advanced hepatocellular cancer (HCC) in patients progressing on or intolerant to sorafenib. H Safran, K Charpentier, G Dubel, G Soares, D Berz, JL Shipley, ... Journal of Clinical Oncology 28 (15_suppl), 4159-4159, 2010 | 6 | 2010 |
| Unintended consequences of duty hours regulation BC Drolet, KD Bishop Academic Medicine 87 (6), 680, 2012 | 5 | 2012 |
| Infiltrative Rash Secondary to Leukemic-Phase Diffuse Large B-Cell Lymphoma With t (14; 18), CDKN2A and MLL Deletion IY Sheng, DO Treaba, KD Bishop Journal of Hematology 6 (4), 90, 2017 | 1 | 2017 |
| Patient expectations of palliative cancer treatment. KE Faricy-Anderson, SM Allen, NJ Freeman, KD Bishop, V Mor Journal of Clinical Oncology 33 (15_suppl), e17703-e17703, 2015 | 1 | 2015 |
| Reduction of emergency department utilization via access to outpatient cancer care. KD Bishop, MA Fenton, T Szymanski, M Begnoche Journal of Clinical Oncology 32 (30_suppl), 128-128, 2014 | 1 | 2014 |
| FOLFOX+ Nab-paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Study H Safran, K Mantripragada, K Perez, K Charpentier, T Miner, T Dipetrillo, ... Gastrointestinal Cancer Research: GCR 7 (4 Suppl 1), S19, 2014 | 1 | 2014 |
| Leukemic-Phase Diffuse Large B-Cell Lymphoma with t (14; 18), CDKN2A and MLL Deletion Presenting with an Infiltrative Skin Rash IY Sheng, DO Treaba, KD Bishop Blood 128 (22), 5419, 2016 | | 2016 |
| Prostate MRI to Evaluate Extra-Prostatic Disease: A Single Center Analysis KD Bishop, JL Layton, M Furman, DJ Grand, AE Mega, JF Renzulli II Int J Cancer Oncol 2 (1), 1-4, 2015 | | 2015 |
| Perspectives on palliative care in a multisite oncology practice. KD Bishop, AM Taber Journal of Clinical Oncology 32 (31_suppl), 52-52, 2014 | | 2014 |
Adam OlszewskiAssociate Professor, Brown University Alpert Medical School在 brown.edu 的电子邮件经过验证
Adam OlszewskiAssociate Professor, Brown University Alpert Medical School在 brown.edu 的电子邮件经过验证
Brian C. DroletVanderbilt University Medical Center在 vanderbilt.edu 的电子邮件经过验证